Amorphous solid dispersion formation via solvent granulation – A case study with ritonavir and lopinavir
Herein, we evaluate the potential of using a simple solvent granulation process to prepare a binary drug amorphous solid dispersion (ASD) containing two anti-HIV drugs, ritonavir and lopinavir. The drugs were granulated onto a mixture of lactose and microcrystalline cellulose, followed by drying to...
Main Authors: | Niraj S. Trasi, Sonal Bhujbal, Qi Tony Zhou, Lynne S. Taylor |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-12-01
|
Series: | International Journal of Pharmaceutics: X |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2590156719300490 |
Similar Items
-
Physical stability and release properties of lumefantrine amorphous solid dispersion granules prepared by a simple solvent evaporation approach
by: Niraj S. Trasi, et al.
Published: (2020-12-01) -
Pharmaceutical amorphous solid dispersion: A review of manufacturing strategies
by: Sonal V. Bhujbal, et al.
Published: (2021-08-01) -
Recurrent oedema associated with the co-formulation of lopinavir and ritonavir Edema recorrente associado à co-formulação de lopinavir e ritonavir
by: Jorge Francisco C. Pinto, et al.
Published: (2004-08-01) -
Toxicity for warfarine switching from lopinavir/ritonavir to dolutegravir
by: Ana Pelufo-Pellicer, et al.
Published: (2017-03-01) -
Modulations of human placental transfer of lopinavir, ritonavir and enfuvirtide
by: Farinotti Robert, et al.
Published: (2010-05-01)